| 1. |
- Güzey, Cüneyt, et al.
(författare)
-
Radioligand binding to brain dopamine and serotonin receptors and transporters in Parkinson's disease : relation to gene polymorphisms
- 2012
-
Ingår i: International Journal of Neuroscience. - New York : Gordon and Breach. - 0020-7454 .- 1563-5279 .- 1543-5245. ; 122:3, s. 124-132
-
Tidskriftsartikel (refereegranskat)abstract
- The influence of variations in genes coding for dopamine and serotonin transporters and receptors on the expression of these structures in the brains of patients with Parkinson's disease (PD) is not known. In order to investigate the significance of dopamine and serotonin transporter and receptor gene polymorphisms on the expression of dopamine and serotonin transporters and the dopamine D(2) and serotonin 5HT(2A) receptors in brain tissue in PD, we conducted a study on brain autopsy material from 16 patients diagnosed with clinical PD and 11 controls. The polymorphisms studied were DAT1 VTNR, DRD2 Taq1A, 5HTTLPR, and 5HTR2A 102 T>C, 516 C>T, His425Tyr and Thr25Asn. Compared to control subjects, patients with PD had a significantly lowered radioligand binding to the dopamine transporter in nucleus caudatus (P = 0.001) and putamen (P = 0.008), and to the serotonin transporter in gyrus cingulatus (P = 0.010) and nucleus caudatus (P = 0.032). We did not observe any significant associations between genetic polymorphisms and the extent of radioligand binding or between the polymorphisms and a diagnosis of PD. In conclusion, the density of brain dopamine and serotonin transporters in patients with PD was reduced. However, there were no associations between the investigated genotypes and the expression of the corresponding receptors and transporters.
|
|
| 2. |
- Sigurdh, Jeanette, et al.
(författare)
-
Platelet serotonin transporter and 5-HT2A receptor binding in adolescents with eating disorders
- 2013
-
Ingår i: International Journal of Neuroscience. - : Informa UK Limited. - 0020-7454 .- 1563-5279 .- 1543-5245. ; 123:5, s. 333-338
-
Tidskriftsartikel (refereegranskat)abstract
- The pathogenetic involvement of the serotonergic system in eating disorders is an established finding. Conclusions from platelet studies are based on results from investigations of subjects with a mean age of 20 years or more. The aim was to investigate whether previous findings in adults are valid also for adolescents who are examined within a relatively short interval after the onset of the eating disorder. [H-3] paroxetine binding to the platelet serotonin transporter and [H-3] lysergic acid diethylamide ([H-3] LSD) binding to the 5-HT2A receptor was studied in 15 female adolescents with eating disorders (11 with anorexia nervosa and 4 with clearly anorectic eating behaviour not fulfilling the criteria for anorexia nervosa) and 32 controls. The patients revealed a higher density of serotonin transporters and a lower density of 5-HT2A receptors compared with healthy controls of the same age (775 +/- 165 vs. 614 +/- 111 fmol/mg protein (p = 0.003) for [H-3] paroxetine binding and 215 +/- 59 vs. 314 +/- 151 fmol/mg protein (p = 0.005) for [H-3] LSD binding). The findings of increased density of platelet serotonin transporters and reduced density of 5-HT2A receptors differ from previous results in older patients. The lower patient age and the short duration of disease in the present study, possibly in conjunction with variations in stress-related psychological and biological factors, may have caused these differences. Although the present findings contradict prevailing evidence, they add further information concerning the nature of serotonergic involvement in eating disorders and indicate that demographic and course-related factors might influence the regulation of the serotonin system in these disorders.
|
|
